ENOV NYSE Week ended 31 Jul 2026

Weekly Investor Report

Enovis Corp · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 29.15 USD
7.8% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 21.0% above the Trend Line and sits at 66.1% of its 52-week range. The latest completed week returned 7.8%, after a 29.6% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is inexpensive relative to peers. Options positioning is volatility with 51/100 conviction, while the latest news-sentiment score is 58/100. Near-term considerations: volume confirmation is below normal; earnings are due in 5d.

Setup score 50 out of 100
Latest Close 29.15 USD 31 Jul 2026
1W Return 7.8% latest completed week
4W Return 29.6% short-term follow-through
12W Return 9.9% quarterly tape
Trend Breadth 3.8% 2 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 34.76% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.8% Latest completed week; four-week move 29.6%. Indicator stack 9/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 34.76% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 51/100 conviction; expected move 26.1%. News sentiment 58/100 55 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 21.0% above the Trend Line and sits at 66.1% of its 52-week range. The latest completed week returned 7.8%, after a 29.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2312-week average 0.11

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.23Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 29.6% over four weeks, 9.9% over 12 weeks, and 13.2% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W7.8%
4W29.6%
12W9.9%
26W32.3%
52W13.2%
Active trend streak2 weeks
Active weeks in one year2
Trend breadth3.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.08Latest activity-pressure read.
Pressure change490.7%Four-week change in activity pressure.
Leadership0.62Latest relative-leadership reading.
RS change102.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength54/100Blend of value, momentum, and quality. Underlying universe rank 47; rank 1 is best.
Value82/100Relative valuation strength. Underlying universe rank 19; rank 1 is best.
Quality16/100Profitability and accounting quality. Underlying universe rank 85; rank 1 is best.
Momentum23/100Medium-term price momentum. Underlying universe rank 78; rank 1 is best.
Growth34/100Revenue and earnings growth. Underlying universe rank 67; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.7x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
15.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
56.8%
Gross profit retained from each unit of revenue.
Operating margin
-45.9%
Operating profit retained from revenue.
Free-cash-flow margin
19.7%
Free cash flow generated from revenue.
Return on invested capital
-27.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
6.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
34.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.1%
Net share repurchases relative to market value.
Shareholder yield
-0.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

ENOV shows volatility options pressure with a 51/100 conviction score, put-call volume ratio of 0.19, expected move of 26.1%, and Sharemaestro trend signal active.

Conviction51/100
Expected move26.1%
Put/call volume0.19
Pressure78
Speculation11
Volatility96
Trend agreement22
Open options detail
Insider activity16 / 2

16 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment58/100

Weighted news tone is neutral across 55 relevant articles.

23 positive · 28 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move26.1%Nearest-chain priced movement where available.
52-week drawdown-15.0%Distance below the 52-week high.
13-week volatility6.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+14.4%Week of 10 Jul.
Worst week-8.4%Week of 24 Apr.
Latest week+7.8%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains4
Flat weeks0
Modest losses7
Sharp losses6
Recent vol6.9%13-week weekly-return volatility.
Base vol6.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew6.1% / -5.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape43/100

Trend, activity pressure, participation, and risk combine to a 43/100 tape read.

 Indicator analysis39/100

Latest 12-week confirmation: trend 2/12, activity pressure 12/12, relative leadership 1/12.

Activity pressure 0.23; No reversal markers Next-Week ExpectancyNegative 34.76%

Next-week expectancy is negative with a 34.76% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors43/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 72; Small Cap Core rank 30 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options41/100

ENOV shows volatility options pressure with a 51/100 conviction score, put-call volume ratio of 0.19, expected move of 26.1%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 26.1% Sentiment58/100

Weighted news tone is neutral across 55 relevant articles.

Are Enovis’ (ENOV) Sales Declines Quietly Rewriting Its Core Growth and Capital Allocation Story? Insiders16 / 2

16 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings5d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202629.15 USD7.8%24.10 USD39.70 USD1.080.624.9MOn
24 Jul 202627.03 USD-0.1%24.01 USD39.90 USD0.86-5.813.9MOn
17 Jul 202627.07 USD5.1%24.02 USD40.13 USD0.78-6.555.1MOff
10 Jul 202625.75 USD14.4%24.01 USD40.37 USD0.50-12.747.1MOff
3 Jul 202622.50 USD-0.9%24.04 USD40.62 USD0.18-23.506.6MOff
26 Jun 202622.71 USD3.4%24.19 USD40.89 USD0.19-22.035.9MOff
19 Jun 202621.97 USD0.8%24.44 USD41.16 USD0.14-27.114.8MOff
12 Jun 202621.80 USD-8.3%24.67 USD41.40 USD0.37-27.755.6MOff
5 Jun 202623.78 USD4.9%24.94 USD41.65 USD0.65-21.655.2MOff
29 May 202622.68 USD-6.2%25.08 USD41.86 USD0.90-27.874.5MOff
22 May 202624.19 USD-0.4%25.37 USD42.08 USD1.00-22.795.3MOff
15 May 202624.29 USD-8.4%25.66 USD42.26 USD1.01-22.607.2MOff
8 May 202626.52 USD12.3%25.89 USD42.46 USD0.89-16.406.5MOff
1 May 202623.62 USD-2.0%26.00 USD42.65 USD0.61-24.574.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.